Remote monitoring of patients with implanted cardiac devices

Clinical Cardiology

Volumn 33, Issue 1, 2010, Pages 10-17

  Kusumoto, Fred M ^a   Goldschlager, Nora ^b,c  

^a MAYO CLINIC   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER; DEFIBRILLATOR; ELECTROCARDIOGRAM; FAX; FOLLOW UP; HEALTH CARE COST; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HOME MONITORING; HUMAN; IMPLANT; MEDICAL INFORMATION; MEDICAL INSTRUMENTATION; MEDICAL LIABILITY; MOBILE PHONE; PACEMAKER; PATIENT CARE; PATIENT MONITORING; PHYSICIAN; RECORDER; TELEMEDICINE; TELEPHONE;

ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART DISEASES; HEMODYNAMICS; HUMANS; REMOTE SENSING TECHNOLOGY; UNITED STATES;

EID: 75149162574     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20688     Document Type: Article

References (34)

1. Wilkoff BL, Auricchio A, Brugada J, et al; Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm. 2008;5(6):907-925.
2. Sweesy MW, Erickson SL, Crago JA, et al. Analysis of the effectiveness of in-office and transtelephonic follow-up in terms of pacemaker system complications. Pacing Clin Electrophysiol. 1994;17(11 Pt 2):2001-2003.
3. Raatikainen MJ, Uusimaa P, van Ginneken MM, et al. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace. 2008;10(10):1145-1151.
4. Heidbüchel H, Lioen P, Foulon S, et al. Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator. Europace. 2008;10(3):351-357.
5. Ricci RP, Morichelli L, Santini M. Home monitoring remote control of pacemaker and implantable cardioverter defibrillator patients in clinical practice: impact on medical management and health-care resource utilization. Europace. 2008;10(2):164-170.
6. Schoenfeld MH, Compton SJ, Mead RH, et al. Remote monitoring of implantable cardioverter defibrillators: a prospective analysis. Pacing Clin Electrophysiol. 2004;27(6 Pt 1):757-763.
7. Varma N, Stambler B, Chun S. Detection of atrial fibrillation by implanted devices with wireless data transmission capability. Pacing Clin Electrophysiol. 2005;28(suppl 1):S133-S136.
8. Hauser RG, Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration manufacturer and user facility device experience database. Heart Rhythm. 2004;1(4):399-405.
9. Maisel WH, Kramer DB. Implantable cardioverter-defibrillator lead performance. Circulation. 2008;117(21):2721-2723.
10. Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007; 115(19):2474-2480.
11. Neuzil P, Taborsky M, Holy F, et al. Early automatic remote detection of combined lead insulation defect and ICD damage. Europace. 2008;10(5):556-557.
12. Spencker S, Coban N, Koch L, et al. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):409-411.
13. Hammill SC, Kremers MS, Stevenson LW, et al. Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm. 2008;5(9):1359-1363.
14. Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through home monitoring technology improves detection and clinical management of atrial fibrillation. Europace. 2009;11(1):54-61.
15. Calkins H, Brugada J, Packer DL, et al; European Heart Rhythm Association (EHRA); European Cardiac Arrhythmia Scoiety (ECAS); American College of Cardiology (ACC); American Heart Association (AHA); Society of Thoracic Surgeons (STS). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007 4(6):816-861. Epub 2007 Apr 30. Erratum in: Heart Rhythm. 2009 6(1):148.
16. Page RL, Tilsch TW, Connolly SJ, et al; Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide. Circulation. 2003;107(8):1141-1145.
17. Kadish A, Dyer A, Daubert JP, et al; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151-2158.
18. Sacher F, Probst V, Bessouet M, et al. Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. Europace. 2009;Feb 14.
19. Jehn M, Schmidt-Trucksäss A, Schuster T, et al. Daily walking performance as an independent predictor of advanced heart failure: prediction of exercise capacity in chronic heart failure. Am Heart J. 2009;157(2):292-298.
20. Walsh JT, Charlesworth A, Andrews R, Hawkins M, Cowley AJ. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol. 1997;79(10):1364-1369.
21. Goldberg LR, Piette JD, Walsh MN, et al; WHARF Investigators. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146(4):705-712.
22. Chaudhry SI, Barton B, Mattera J, Spertus J, Krumholz HM. Randomized trial of Telemonitoring to Improve Heart Failure Outcomes (Tele-HF): study design. J Card Fail. 2007;13(9):709-714.
23. Bourge RC, Abraham WT, Adamson PB, et al; COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073-1079.
24. Frantz RP, Benza RL, Kjellström B, et al. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2008;27(7):780-788.
25. Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112(6):841-848.
26. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359(10):1009-1017.
27. Adamson PB, Smith AL, Abraham WT, et al; InSync III Model 8042 and Attain OTW Lead Model 4193 Clinical Trial Investigators. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110(16):2389-2394.
28. Fischell TA, Fischell DR, Fischell RE, et al. Real-time detection and alerting for acute ST-segment elevation myocardial ischemia using an implantable, high-fidelity, intracardiac electrogram monitoring system with long-range telemetry in an ambulatory porcine model. J Am Coll Cardiol. 2006;48(11):2306-2314.
29. Asbach S, Weiss I, Wenzel B, et al. Intrathoracic far-field electrocardiogram allows continuous monitoring of ischemia after total coronary occlusion. Pacing Clin Electrophysiol. 2006;29(12):1334-1340.
30. Venugopal D, Patterson R, Jhanjee R, et al. Subcutaneous bioimpedance recording: assessment of a method for hemodynamic monitoring by implanted devices. J Cardiovasc Electrophysiol. 2009;20(1):76-81.
31. Whitten PS, Mair FS, Haycox A, et al. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434-1437.
32. Raatikainen MJ, Uusimaa P, van Ginneken MM, et al. Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up. Europace. 2008;10(10): 1145-1151.
33. Varma N. Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. Am Heart J. 2007;154(6):1029-1034.
34. Winters SL, Kusumoto FM, Miller JM, et al. The role of the Heart Rhythm Society in integrating the healthcare enterprise. Heart Rhythm. 2007;4(1):122-124.